OBJECTIVE: To identify markers associated with in-hospital death in patients with coronavirus disease 2019 (COVID-19)-associated pneumonia. PATIENTS AND METHODS: A retrospective cohort study was conducted of 140 patients with moderate to critical COVID-19-associated pneumonia requiring oxygen supplementation admitted to the hospital from January 28, 2020, through February 28, 2020, and followed up through March 13, 2020, in Union Hospital, Wuhan, China. Oxygen saturation (SpO2) and other measures were tested as predictors of in-hospital mortality in survival analysis. RESULTS: Of 140 patients with COVID-19-associated pneumonia, 72 (51.4%) were men, with a median age of 60 years. Patients with SpO2 values of 90% or less were older and were more likely to be men, to have hypertension, and to present with dyspnea than those with SpO2 values greater than 90%. Overall, 36 patients (25.7%) died during hospitalization after median 14-day follow-up. Higher SpO2 levels after oxygen supplementation were associated with reduced mortality independently of age and sex (hazard ratio per 1-U SpO2, 0.93; 95% CI, 0.91 to 0.95; P<.001). The SpO2 cutoff value of 90.5% yielded 84.6% sensitivity and 97.2% specificity for prediction of survival. Dyspnea was also independently associated with death in multivariable analysis (hazard ratio, 2.60; 95% CI, 1.24 to 5.43; P=.01). CONCLUSION: In this cohort of patients with COVID-19, hypoxemia was independently associated with in-hospital mortality. These results may help guide the clinical management of patients with severe COVID-19, particularly in settings requiring strategic allocation of limited critical care resources. TRIAL REGISTRATION: Chictr.org.cn Identifier: ChiCTR2000030852.

Department of Cardiovascular Medicine Mayo Clinic Rochester MN

Department of Cardiovascular Medicine Mayo Clinic Rochester MN; Department of Internal Medicine Brno Municipal Hospital School of Medicine of Masaryk University Brno Czech Republic

Department of Cardiovascular Medicine Mayo Clinic Rochester MN; Guang An Men Hospital China Academy of Medical Sciences Beijing China

Department of Cardiovascular Medicine Mayo Clinic Rochester MN; Pennington Biomedical Research Center Baton Rouge LA

Department of Respiratory and Critical Medicine of Beijing Anzhen Hospital Capital Medical University Beijing China

Mayo Clin Proc. 2020 Jun;95(6):1094-1096. doi: 10.1016/j.mayocp.2020.04.021. PubMed

See more in PubMed

Grasselli G., Pesenti A., Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. https://doi.org/10.1001/jama.2020.4031 [published online March 13, 2020]. JAMA. PubMed DOI

White D.B., Lo B. A framework for rationing ventilators and critical care beds during the COVID-19 pandemic. https://doi.org/10.1001/jama.2020.5046 [published online March 27, 2020]. JAMA. PubMed DOI

Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. https://doi.org/10.1001/jama.2020.2648 [published online February 24, 2020]. JAMA. PubMed DOI

Arentz M., Yim E., Klaff L. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. https://doi.org/10.1001/jama.2020.4326 [published online March 19, 2020]. JAMA. PubMed DOI PMC

Wu C., Chen X., Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. https://doi.org/10.1001/jamainternmed.2020.0994 [published online March 13, 2020]. JAMA Intern Med. PubMed DOI PMC

Yang X., Yu Y., Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. https://doi.org/10.1016/S2213-2600(20)30079-5 [published online February 24, 2020]. Lancet Respir Med. PubMed DOI PMC

National Health Committee of the People’s Republic of China New coronavirus pneumonia diagnosis and treatment plan. http://www.nhc.gov.cn

Bauchner H., Golub R.M., Zylke J. Editorial concern-possible reporting of the same patients with COVID-19 in different reports. https://doi.org/10.1001/jama.2020.3980 [published online March 16, 2020]. JAMA. PubMed DOI

Jin J.-M., Bai P., He W. Gender differences in patients with COVID-19: focus on severity and mortality. https://doi.org/10.1101/2020.02.23.20026864 [published online March 5, 2020]. medRxiv. PubMed DOI PMC

Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. PubMed PMC

Loke Y.K., Kwok C.S., Niruban A., Myint P.K. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax. 2010;65(10):884–890. PubMed

Jochems S.P., Marcon F., Carniel B.F. Inflammation induced by influenza virus impairs human innate immune control of pneumococcus. Nat Immunol. 2018;19(12):1299–1308. PubMed PMC

Corman V.M., Landt O., Kaiser M. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3) doi: 10.2807/1560-7917.ES.2020.25.3.2000045. PubMed DOI PMC

Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks

In Reply - Does Hypoxia Itself Beget Worsening Hypoxemia in COVID-19?

Progressive Hypoxia: A Pivotal Pathophysiologic Mechanism of COVID-19 Pneumonia